1370007-53-6 Usage
Uses
Used in Medicinal Chemistry Research:
7-bromo-3H,4H-pyrrolo[2,1-f][1,2,4]triazin-4-one is used as a key component in the development of potential pharmaceutical drugs for various diseases and conditions. Its distinctive structure allows for the creation of new drug candidates with diverse therapeutic properties.
Used as a Building Block in Organic Synthesis:
In the field of organic chemistry, 7-bromo-3H,4H-pyrrolo[2,1-f][1,2,4]triazin-4-one is utilized as a building block for synthesizing a range of derivatives. These derivatives may exhibit biological activities that are beneficial in the development of new medications and treatments.
Used as an Intermediate in Complex Organic Molecule Production:
7-bromo-3H,4H-pyrrolo[2,1-f][1,2,4]triazin-4-one also serves as a useful intermediate in the synthesis of more complex organic molecules. Its presence in these processes is crucial for the production of advanced chemical compounds with specific applications in various industries.
Used in Drug Discovery and Development:
Chemists and researchers in the field of drug discovery and development are particularly interested in 7-bromo-3H,4H-pyrrolo[2,1-f][1,2,4]triazin-4-one due to its properties and potential applications. Its versatility and the possibility of creating new derivatives make it a promising candidate for further exploration and innovation in pharmaceutical research.
Check Digit Verification of cas no
The CAS Registry Mumber 1370007-53-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,0,0,0 and 7 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1370007-53:
(9*1)+(8*3)+(7*7)+(6*0)+(5*0)+(4*0)+(3*7)+(2*5)+(1*3)=116
116 % 10 = 6
So 1370007-53-6 is a valid CAS Registry Number.
1370007-53-6Relevant articles and documents
AMINOPYRROLOTRIAZINES AS KINASE INHIBITORS
-
Page/Page column 190; 191, (2019/08/12)
The disclosure relates to compounds of formula I which are useful as kinase modulators including RIPK1 modulation. The disclosure also provides methods of making and using the compounds for example in treatments related to necrosis or inflammation as well as other indications.
ACYCLIC ANTIVIRALS
-
Paragraph 0321, (2017/09/28)
Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HBV and/or HDV and/or HIV infection with one or more nucleotide analogs
3H-THIENO[3,4]PYRIMIDIN-4-ONEAND PYRROLOPYRIMID-4-ONE AS GRAM-POSITIVE ANTIBACTERIAL AGENTS
-
Page/Page column 88, (2015/09/28)
The invention relates to novel heteroaromatic derivatives of formula (I) and their addition salts thereof with acids and bases; their preparation, their use as drugs and pharmaceutical compositions and associations containing them. wherein A, B, T, V, X and Y represent organic substituents as defined herein, The compounds of formula (I) are able to inhibit the activity of the Gram-positive bacterial DltA enzyme and they are used to prevent and/or treat Gram-positive bacterial infections in humans or animals, alone or in association with antibacterials, antivirulence agents or drugs reinforcing the host innate immunity,
SULFONAMIDE, SULFAMATE, AND SULFAMOTHIOATE DERIVATIVES
-
, (2012/04/05)
The disclosure provides biologically active compounds of formula (I): and pharmaceutically acceptable salts thereof, compositions containing these compounds, and methods of using these compounds in a variety applications, such as treatment of diseases or disorders associated with E1 type activating enzymes, and with Nedd8 activating enzyme (NAE) in particular.
